Joel Greenblatt's TMO Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 71.8K shares of Thermo Fisher Scientific Inc. (TMO) worth $34.81 M, representing 0.15% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 45 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in TMO, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2025, adding 41.4K shares. Largest reduction occurred in Q2 2019, reducing 23.9K shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Thermo Fisher Scientific (TMO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Thermo Fisher Scientific (TMO) Trades by Joel Greenblatt
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2014 | +3,314 | New Buy | 3,314 | $121.61 |
| Q4 2014 | -3,314 | Sold Out | 3,314 | $0.00 |
| Q1 2016 | +4,687 | New Buy | 4,687 | $141.67 |
| Q2 2016 | -2,897 | Reduce 61.81% | 1,790 | $147.49 |
| Q3 2016 | -1,790 | Sold Out | 1,790 | $0.00 |
| Q1 2017 | +10,891 | New Buy | 10,891 | $153.61 |
| Q2 2017 | -8,413 | Reduce 77.25% | 2,478 | $174.33 |
| Q3 2017 | -2,478 | Sold Out | 2,478 | $0.00 |
| Q3 2018 | +13,590 | New Buy | 13,590 | $244.08 |
| Q4 2018 | +25,830 | Add 190.07% | 39,420 | $223.80 |
| Q1 2019 | +1,181 | Add 3.00% | 40,601 | $273.71 |
| Q2 2019 | -23,940 | Reduce 58.96% | 16,661 | $293.68 |
| Q3 2019 | -13,498 | Reduce 81.02% | 3,163 | $291.18 |
| Q4 2019 | -1,715 | Reduce 54.22% | 1,448 | $324.59 |
| Q1 2020 | +1,075 | Add 74.24% | 2,523 | $283.79 |
| Q2 2020 | -1,009 | Reduce 39.99% | 1,514 | $362.62 |
| Q3 2020 | +11,093 | Add 732.69% | 12,607 | $441.50 |
| Q4 2020 | +17,365 | Add 137.74% | 29,972 | $465.77 |
| Q1 2021 | -2,136 | Reduce 7.13% | 27,836 | $456.39 |
| Q2 2021 | -15,202 | Reduce 54.61% | 12,634 | $504.43 |
| Q3 2021 | -9,953 | Reduce 78.78% | 2,681 | $571.43 |
| Q4 2021 | +6,863 | Add 255.99% | 9,544 | $667.23 |
| Q1 2022 | -2,561 | Reduce 26.83% | 6,983 | $590.72 |
| Q2 2022 | -5,089 | Reduce 72.88% | 1,894 | $543.29 |
| Q3 2022 | +75 | Add 3.96% | 1,969 | $507.36 |
| Q4 2022 | +2,330 | Add 118.33% | 4,299 | $550.69 |
| Q1 2023 | -1,798 | Reduce 41.82% | 2,501 | $576.37 |
| Q2 2023 | -702 | Reduce 28.07% | 1,799 | $521.75 |
| Q3 2023 | +855 | Add 47.53% | 2,654 | $506.17 |
| Q4 2023 | +2,246 | Add 84.63% | 4,900 | $530.79 |
| Q1 2024 | +9,218 | Add 188.12% | 14,118 | $581.21 |
| Q2 2024 | +7,164 | Add 50.74% | 21,282 | $553.00 |
| Q3 2024 | +2,125 | Add 9.98% | 23,407 | $618.57 |
| Q4 2024 | +5,944 | Add 25.39% | 29,351 | $520.23 |
| Q1 2025 | +8,993 | Add 30.64% | 38,344 | $497.60 |
| Q2 2025 | +41,418 | Add 108.02% | 79,762 | $405.46 |
| Q3 2025 | -7,986 | Reduce 10.01% | 71,776 | $485.02 |
Joel Greenblatt's Thermo Fisher Scientific Investment FAQs
Joel Greenblatt first purchased Thermo Fisher Scientific Inc. (TMO) in Q3 2014, acquiring 3,314 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Thermo Fisher Scientific Inc. (TMO) for 45 quarters since Q3 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's largest addition to Thermo Fisher Scientific Inc. (TMO) was in Q2 2025, adding 79,762 shares worth $32.34 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 71,776 shares of Thermo Fisher Scientific Inc. (TMO), valued at approximately $34.81 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Thermo Fisher Scientific Inc. (TMO) represents approximately 0.15% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's peak holding in Thermo Fisher Scientific Inc. (TMO) was 79,762 shares, as reported at the end of Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.